Chondromyxoid fibroma is a benign neoplasm developing in bone tissue, diagnosed in a very small number of patients. Research shows that this tumor accounts for only 0.7-1% of all bone cancers. Characteristic signs of the pathology are often weakly expressed in the early stages, which explains the difficulty of timely diagnosis. Thanks to the use of advanced surgical techniques, the treatment of chondromyxoid fibroma in Israel is successfully performed for patients of all age groups. Comprehensive therapy, including the most effective methods for the patient, ensures a favorable prognosis and complete recovery in almost 100% of cases. Postoperative defects are corrected through reconstructive plastic surgery, and after the recovery period, the patient undergoes a full rehabilitation course.
To prescribe an adequate treatment program, a comprehensive diagnostic examination is necessary. Israeli clinics are equipped with the latest technology, allowing for prompt and accurate diagnosis. The diagnosis and treatment of the disease are carried out by highly qualified orthopedic surgeons with many years of experience who regularly undergo training in leading clinics worldwide. Numerous patient reviews indicate that, with the same quality of medical services, the cost of treatment in Israel is significantly lower than in Western European countries and the USA.
Treatment Methods for the Disease
The common method for treating chondromyxoid fibroma is the surgical removal of the neoplasm. Currently, in Israeli clinics, as well as in medical centers of other countries with developed medicine, no other therapeutic methods for this pathology are accepted in clinical practice. Treatment should be performed as soon as possible, as there is a risk of malignant transformation of the tumor.
The following types of surgical interventions are indicated for the removal of chondromyxoid fibroma:
- Marginal resection of the affected bone fragment — the most effective and safe method for the patient, primarily used in Israeli clinics. The excision of the bone tissue involved in the tumor process is performed without damaging the bone and compromising its integrity. The procedure is carried out in an area limited by healthy, non-pathological tissues. In most cases, when assessing the necessary volume of excision, the surgeon retreats from the neoplasm by at least 5 millimeters. The recommended retreat distance may be greater, depending on the bone in which the chondromyxoid fibroma is localized. If viable cells with pathological changes remain in the bed after the neoplasm is removed, there is a likelihood of recurrence after some time. To prevent this, a larger fragment of bone tissue is excised during the procedure. If the marginal resection is performed following all guidelines, the risk of recurrence of the fibroma is negligible.
- Curettage — the removal of tumor tissues from the affected bone area using a special surgical curette, which resembles a spoon. The only defect that develops after this method of surgical removal of the neoplasm is a small depression in the bone tissue. In practice, this method of tumor removal carries a high risk of retaining pathologically altered cells, which serve as the cause of recurrence. For this reason, curettage is rarely used in Israeli clinics.
In some cases, surgical removal of chondromyxoid fibroma is preceded by sessions of radiation therapy. The procedure is indicated because ionizing radiation significantly reduces the size of the neoplasm, alleviates painful symptoms, and facilitates subsequent surgical intervention. However, studies have shown that radiation therapy increases the likelihood of malignant transformation of the tumor. For this reason, radiation is rarely prescribed in Israeli clinics.
For approximately a week after the surgical removal of the fibroma, the patient requires monitoring by doctors. After this period, the patient is discharged from the hospital and referred for a rehabilitation course. The rehabilitation program is individually tailored for each patient and includes physiotherapy aimed at restoring movement disorders in the limb and medications to strengthen the immune system. For timely diagnosis of possible recurrence of the pathology, regular examinations are recommended for several years after treatment.
Bone deformities of significant size resulting from the surgical removal of chondromyxoid fibroma are corrected using allogeneic or autogenous bone grafting. In the first case, the patient receives a transplant of a compatible donor's bone fragment, while autotransplantation involves using a section of healthy bone from the patient themselves. Allogeneic transplantation does not require an additional operation to obtain bone material, while the transplantation of the patient's own tissue does not lead to rejection and heals faster.
Send your records — an Ichilov physician will reply within 1–2 days, free of charge.
How the Diagnosis of the Disease is Conducted
When chondromyxoid fibroma is suspected, the patient is referred for a comprehensive diagnostic examination necessary to differentiate the pathology from musculoskeletal diseases with similar symptoms. Additionally, establishing the nature of the neoplasm is required to differentiate it from malignant chondrosarcoma.
The necessity for a thorough examination is also due to the absence of pronounced clinical symptoms. The degree of expression of characteristic signs of the disease depends on the patient's age. In children, rapid progression of the pathology, severe pain, and impairment of functional abilities of the affected limb are observed. In adulthood, the pathology may be asymptomatic for a long period.
In Israeli clinics, thorough diagnostics take, on average, no more than three days.
First Day
Upon arrival at the clinic, the patient is referred for a consultation with the attending physician. During the appointment, the doctor reviews the medical history, conducts a physical examination, identifies possible causes of the disease, and prescribes necessary examinations.
Second Day
Completion of the prescribed examinations, including:
- X-ray — a mandatory examination that allows for the identification and assessment of the pathological focus, determining its size, which in most cases ranges from 2-7 centimeters in length, and boundaries;
- biopsy — obtaining samples of pathologically altered tissues followed by histological analysis, allowing for the precise determination of the tumor's nature and differentiation from chondrosarcoma.
Third Day
A medical council, consisting of the attending physician and several specialized experts, reviews the obtained examination results, makes a final diagnosis, and develops a treatment program.
What is the Cost of Treatment for the Disease
The cost is determined after the patient undergoes examinations and the appointment of treatment procedures. Overall, the price of treatment in Israel is 30-50% lower than in Western European and American clinics of corresponding levels.
Advantages of Treatment in Israel
- Experienced qualified doctors.
- Accurate diagnostics on high-tech equipment.
- Professional execution of tumor removal surgery.
- Complete elimination of postoperative bone defects and patient rehabilitation.
- Affordable prices.
Effective treatment will allow you to forget about the disease forever, relieving discomfort and the risk of serious complications. Therefore, upon the appearance of suspicious symptoms, do not hesitate, choose a clinic and start your therapy course.